Jiang S, Zhu D, Wang Y
Cancer Cell Int. 2025; 25(1):68.
PMID: 40011889
PMC: 11866835.
DOI: 10.1186/s12935-025-03668-3.
Cai P, Sun H, Jiang T, Li H, Huang D, Hao X
Cancer Immunol Immunother. 2025; 74(4):114.
PMID: 39998561
PMC: 11861500.
DOI: 10.1007/s00262-025-03960-1.
Shi H, Wang W, Luo J, Song G, Han R
Sci Rep. 2025; 15(1):6549.
PMID: 39994401
PMC: 11850725.
DOI: 10.1038/s41598-025-90817-3.
Martinis E, Tonon S, Colamatteo A, La Cava A, Matarese G, Pucillo C
Nat Immunol. 2025; 26(3):366-377.
PMID: 39984733
DOI: 10.1038/s41590-025-02102-0.
Armstrong D, Chang C, Hong M, Green L, Shen Y, Hudson W
Sci Adv. 2025; 11(7):eads4227.
PMID: 39937892
PMC: 11817953.
DOI: 10.1126/sciadv.ads4227.
Safety and efficacy of neoadjuvant therapy with tislelizumab plus chemotherapy for locally advanced head and neck squamous cell carcinoma: a single-arm, retrospective study.
Liang H, Liang W, Tian J, Zheng S, Su Y, Huang P
Cancer Immunol Immunother. 2025; 74(3):108.
PMID: 39932534
PMC: 11813832.
DOI: 10.1007/s00262-025-03953-0.
Identification of CD66c as a potential target in gastroesophageal junction cancer for antibody-drug conjugate development.
Zhang P, Tao C, Xie H, Yang L, Lu Y, Xi Y
Gastric Cancer. 2025; .
PMID: 39918687
DOI: 10.1007/s10120-025-01584-z.
S100A13-driven interaction between pancreatic adenocarcinoma cells and cancer-associated fibroblasts promotes tumor progression through calcium signaling.
Xia L, Guo X, Lu D, Jiang Y, Liang X, Shen Y
Cell Commun Signal. 2025; 23(1):51.
PMID: 39871271
PMC: 11773924.
DOI: 10.1186/s12964-025-02049-7.
Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies.
Du Y, Yang Y, Zheng B, Zhang Q, Zhou S, Zhao L
Oncogene. 2025; 44(7):409-426.
PMID: 39863748
PMC: 11810799.
DOI: 10.1038/s41388-025-03273-8.
Integrative analysis of single-cell and transcriptome sequencing with experimental validation reveals PKHD1L1 as a novel biomarker in lung adenocarcinoma.
Zhang X, Wang J, Su H, Liu X
Sci Rep. 2025; 15(1):2795.
PMID: 39843484
PMC: 11754870.
DOI: 10.1038/s41598-025-85981-5.
Immune Microenvironment in Breast Cancer Metastasis.
Qian B, Ma R
Adv Exp Med Biol. 2025; 1464():413-432.
PMID: 39821036
DOI: 10.1007/978-3-031-70875-6_20.
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial).
Ressler J, Plaschka M, Silmbrod R, Bachmayr V, Shaw L, Silly T
Nat Cancer. 2025; 6(1):51-66.
PMID: 39820126
PMC: 11779647.
DOI: 10.1038/s43018-024-00879-x.
Single-cell transcriptomics unveils multifaceted immune heterogeneity in early-onset versus late-onset cervical cancer.
Chen Q, Deng D, Zhu H, Li S
World J Surg Oncol. 2025; 23(1):12.
PMID: 39810181
PMC: 11730844.
DOI: 10.1186/s12957-025-03654-z.
Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents.
Fouillet J, Torchio J, Rubira L, Fersing C
Biology (Basel). 2025; 13(12.
PMID: 39765634
PMC: 11673949.
DOI: 10.3390/biology13120967.
Molecular dynamics simulation based prediction of T-cell epitopes for the production of effector molecules for liver cancer immunotherapy.
Zafar S, Bai Y, Muhammad S, Guo J, Khurram H, Zafar S
PLoS One. 2025; 20(1):e0309049.
PMID: 39752339
PMC: 11698456.
DOI: 10.1371/journal.pone.0309049.
The prognostic and immunomodulatory role of the MMR system in patients with stomach adenocarcinoma.
Tian Z, Yang L, Yang R, Yang W
Sci Rep. 2025; 15(1):180.
PMID: 39748125
PMC: 11695722.
DOI: 10.1038/s41598-024-84613-8.
B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications.
Wu X, Huang Q, Chen X, Zhang B, Liang J, Zhang B
Theranostics. 2025; 15(2):605-631.
PMID: 39744696
PMC: 11671382.
DOI: 10.7150/thno.105423.
Exploring the tumor microenvironment of colorectal cancer patients post renal transplantation by single-cell analysis.
Zhang J, Mizuuchi Y, Ohuchida K, Hisano K, Shimada Y, Katayama N
Cancer Sci. 2024; 116(2):500-512.
PMID: 39623744
PMC: 11786312.
DOI: 10.1111/cas.16409.
B cell c-Maf signaling promotes tumor progression in animal models of pancreatic cancer and melanoma.
Zhong Q, Hao H, Li S, Ning Y, Li H, Hu X
J Immunother Cancer. 2024; 12(11).
PMID: 39608978
PMC: 11603694.
DOI: 10.1136/jitc-2024-009861.
Tertiary lymphoid structures in ovarian cancer.
Sun G, Liu Y
Front Immunol. 2024; 15:1465516.
PMID: 39569184
PMC: 11576424.
DOI: 10.3389/fimmu.2024.1465516.